Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 825203, 10 pages
http://dx.doi.org/10.1155/2015/825203
Review Article

Antiviral Potential of Algae Polysaccharides Isolated from Marine Sources: A Review

1Department of Medical Microbiology, Tropical Infectious Disease Research and Education Center (TIDREC), Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2Biochemistry Program, Institute of Biological Sciences, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
3The Persian Gulf Marine Biotechnology Research Center, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran

Received 7 April 2015; Revised 7 June 2015; Accepted 15 June 2015

Academic Editor: Sherif Elshahawi

Copyright © 2015 Azin Ahmadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Murrell, S.-C. Wu, and M. Butler, “Review of dengue virus and the development of a vaccine,” Biotechnology Advances, vol. 29, no. 2, pp. 239–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. V. Lazarus, I. Sperle, M. Maticic, and L. Wiessing, “A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region,” BMC Infectious Diseases, vol. 14, supplement 6, article S16, 2014. View at Publisher · View at Google Scholar
  3. M. R. Loutfy, W. Wu, M. Letchumanan et al., “Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy,” PLoS ONE, vol. 8, no. 2, Article ID e55747, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Li, H. Qian, F. Miyamoto et al., “A simple, rapid, and sensitive system for the evaluation of anti-viral drugs in rats,” Biochemical and Biophysical Research Communications, vol. 424, no. 2, pp. 257–261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. De Clercq, “Strategies in the design of antiviral drugs,” Nature Reviews Drug Discovery, vol. 1, no. 1, pp. 13–25, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Yasuhara-Bell and Y. Lu, “Marine compounds and their antiviral activities,” Antiviral Research, vol. 86, no. 3, pp. 231–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. K. Jha and X. Zi-rong, “Biomedical compounds from marine organisms,” Marine Drugs, vol. 2, no. 3, pp. 123–146, 2004. View at Publisher · View at Google Scholar
  8. S. Zorofchian Moghadamtousi, H. Karimian, R. Khanabdali et al., “Anticancer and antitumor potential of fucoidan and fucoxanthin, two main metabolites isolated from brown algae,” The Scientific World Journal, vol. 2014, Article ID 768323, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. C. L. F. de Almeida, H. D. S. Falcão, G. R. D. M. Lima et al., “Bioactivities from marine algae of the genus Gracilaria,” International Journal of Molecular Sciences, vol. 12, no. 7, pp. 4550–4573, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. La Barre, P. Potin, C. Leblanc, and L. Delage, “The halogenated metabolism of brown algae (phaeophyta), its biological importance and its environmental significance,” Marine Drugs, vol. 8, no. 4, pp. 988–1010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Goss and T. Jakob, “Regulation and function of xanthophyll cycle-dependent photoprotection in algae,” Photosynthesis Research, vol. 106, no. 1-2, pp. 103–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Pangestuti and S.-K. Kim, “Biological activities and health benefit effects of natural pigments derived from marine algae,” Journal of Functional Foods, vol. 3, no. 4, pp. 255–266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Pangestuti and S.-K. Kim, “Neuroprotective effects of marine algae,” Marine Drugs, vol. 9, no. 5, pp. 803–818, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. R. B. G. Camara, L. S. Costa, G. P. Fidelis et al., “Heterofucans from the brown seaweed Canistrocarpus cervicornis with anticoagulant and antioxidant activities,” Marine Drugs, vol. 9, no. 1, pp. 124–138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. B. B. da Matta, É. T. de Souza, A. C. de Queiroz et al., “Antinociceptive and anti-inflammatory activity from algae of the Genus Caulerpa,” Marine Drugs, vol. 9, no. 3, pp. 307–318, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S.-H. Eom, Y.-M. Kim, and S.-K. Kim, “Antimicrobial effect of phlorotannins from marine brown algae,” Food and Chemical Toxicology, vol. 50, no. 9, pp. 3251–3255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J.-B. Lee, S. Koizumi, K. Hayashi, and T. Hayashi, “Structure of rhamnan sulfate from the green alga Monostroma nitidum and its anti-herpetic effect,” Carbohydrate Polymers, vol. 81, no. 3, pp. 572–577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. L.-E. Rioux, S. L. Turgeon, and M. Beaulieu, “Structural characterization of laminaran and galactofucan extracted from the brown seaweed Saccharina longicruris,” Phytochemistry, vol. 71, no. 13, pp. 1586–1595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Li, F. Lu, X. Wei, and R. Zhao, “Fucoidan: structure and bioactivity,” Molecules, vol. 13, no. 8, pp. 1671–1695, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Larsen, D. M. S. A. Salem, M. A. E. Sallam, M. M. Mishrikey, and A. I. Beltagy, “Characterization of the alginates from algae harvested at the Egyptian Red Sea coast,” Carbohydrate Research, vol. 338, no. 22, pp. 2325–2336, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-H. Guo, G. W. Skinner, W. W. Harcum, and P. E. Barnum, “Pharmaceutical applications of naturally occurring water-soluble polymers,” Pharmaceutical Science and Technology Today, vol. 1, no. 6, pp. 254–261, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Chevolot, B. Mulloy, J. Ratiskol, A. Foucault, and S. Colliec-Jouault, “A disaccharide repeat unit is the major structure in fucoidans from two species of brown algae,” Carbohydrate Research, vol. 330, no. 4, pp. 529–535, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. G. G. D'Ayala, M. Malinconico, and P. Laurienzo, “Marine derived polysaccharides for biomedical applications: chemical modification approaches,” Molecules, vol. 13, no. 9, pp. 2069–2106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Gerber, J. D. Dutcher, E. V. Adams, and J. H. Sherman, “Protective effect of seaweed extracts for chicken embryos infected with influenza B or mumps virus,” Experimental Biology and Medicine, vol. 99, no. 3, pp. 590–593, 1958. View at Publisher · View at Google Scholar
  25. P. R. Burkholder and G. M. Sharma, “Antimicrobial agents from the sea,” Lloydia, vol. 32, no. 4, pp. 466–483, 1969. View at Google Scholar · View at Scopus
  26. E. F. Deig, D. W. Ehresmann, M. T. Hatch, and D. J. Riedlinger, “Inhibition of herpesvirus replication by marine algae extracts,” Antimicrobial Agents and Chemotherapy, vol. 6, no. 4, pp. 524–525, 1974. View at Publisher · View at Google Scholar · View at Scopus
  27. D. W. Ehresmann, E. F. Deig, M. T. Hatch, L. H. DiSalvo, and N. A. Vedros, “Antiviral substances from California marine algae,” Journal of Phycology, vol. 13, no. 1, pp. 37–40, 1977. View at Publisher · View at Google Scholar
  28. J. T. Richards, E. R. Kern, L. A. Glasgow, J. C. Overall, E. F. Deign, and M. T. Hatch, “Antiviral activity of extracts from marine algae,” Antimicrobial Agents and Chemotherapy, vol. 14, no. 1, pp. 24–30, 1978. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Lahaye, “Developments on gelling algal galactans, their structure and physico-chemistry,” Journal of Applied Phycology, vol. 13, no. 2, pp. 173–184, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Vera, J. Castro, A. Gonzalez, and A. Moenne, “Seaweed polysaccharides and derived oligosaccharides stimulate defense responses and protection against pathogens in plants,” Marine Drugs, vol. 9, no. 12, pp. 2514–2525, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Renn, “Biotechnology and the red seaweed polysaccharide industry: status, needs and prospects,” Trends in Biotechnology, vol. 15, no. 1, pp. 9–14, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. C. B. Buck, C. D. Thompson, J. N. Roberts, M. Müller, D. R. Lowy, and J. T. Schiller, “Carrageenan is a potent inhibitor of papillomavirus infection,” PLoS Pathogens, vol. 2, no. 7, article e69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Grassauer, R. Weinmuellner, C. Meier, A. Pretsch, E. Prieschl-Grassauer, and H. Unger, “Iota-Carrageenan is a potent inhibitor of rhinovirus infection,” Virology Journal, vol. 5, article 107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Zeitlin, K. J. Whaley, T. A. Hegarty, T. R. Moench, and R. A. Cone, “Tests of vaginal microbicides in the mouse genital herpes model,” Contraception, vol. 56, no. 5, pp. 329–335, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. M. E. Gonzalez, B. Alarcon, and L. Carrasco, “Polysaccharides as antiviral agents: antiviral activity of carrageenan,” Antimicrobial Agents and Chemotherapy, vol. 31, no. 9, pp. 1388–1393, 1987. View at Publisher · View at Google Scholar · View at Scopus
  36. M. J. Carlucci, L. A. Scolaro, and E. B. Damonte, “Herpes simplex virus type 1 variants arising after selection with an antiviral carrageenan: lack of correlation between drug susceptibility and syn phenotype,” Journal of Medical Virology, vol. 68, no. 1, pp. 92–98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. M. J. Carlucci, C. A. Pujol, M. Ciancia et al., “Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity,” International Journal of Biological Macromolecules, vol. 20, no. 2, pp. 97–105, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. M. J. Carlucci, L. A. Scolaro, M. D. Noseda, A. S. Cerezo, and E. B. Damonte, “Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice,” Antiviral Research, vol. 64, no. 2, pp. 137–141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. P. C. de SF-Tischer, L. B. Talarico, M. D. Noseda, S. M. P. B. Guimarães, E. B. Damonte, and M. E. R. Duarte, “Chemical structure and antiviral activity of carrageenans from Meristiella gelidium against herpes simplex and dengue virus,” Carbohydrate Polymers, vol. 63, no. 4, pp. 459–465, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. V. R. Zacharopoulos and D. M. Phillips, “Vaginal formulations of carrageenan protect mice from herpes simplex virus infection,” Clinical and Diagnostic Laboratory Immunology, vol. 4, no. 4, pp. 465–468, 1997. View at Google Scholar · View at Scopus
  41. L. B. Talarico and E. B. Damonte, “Interference in dengue virus adsorption and uncoating by carrageenans,” Virology, vol. 363, no. 2, pp. 473–485, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. L. B. Talarico, M. D. Noseda, D. R. B. Ducatti, M. E. R. Duarte, and E. B. Damonte, “Differential inhibition of dengue virus infection in mammalian and mosquito cells by iota-carrageenan,” Journal of General Virology, vol. 92, no. 6, pp. 1332–1342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Tang, F. Chen, and F. Li, “Preparation and potential in vivo anti-influenza virus activity of low molecular-weight κ-carrageenans and their derivatives,” Journal of Applied Polymer Science, vol. 127, no. 3, pp. 2110–2115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Yamada, A. Ogamo, T. Saito, J. Watanabe, H. Uchiyama, and Y. Nakagawa, “Preparation and anti-HIV activity of low-molecular-weight carrageenans and their sulfated derivatives,” Carbohydrate Polymers, vol. 32, no. 1, pp. 51–55, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. E. L. McCandless and J. S. Craigie, “Sulfated polysaccharides in red and brown algae,” Annual Review of Plant Physiology, vol. 30, no. 1, pp. 41–53, 1979. View at Publisher · View at Google Scholar
  46. C. Delattre, T. A. Fenoradosoa, and P. Michaud, “Galactans: an overview of their most important sourcing and applications as natural polysaccharides,” Brazilian Archives of Biology and Technology, vol. 54, no. 6, pp. 1075–1092, 2011. View at Google Scholar · View at Scopus
  47. J. M. Estevez, M. Ciancia, and A. S. Cerezo, “DL-Galactan hybrids and agarans from gametophytes of the red seaweed Gymnogongrus torulosus,” Carbohydrate Research, vol. 331, no. 1, pp. 27–41, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. C. A. Stortz and A. S. Cerezo, “Novel findings in carrageenans, agaroids and hybrids red seaweed galactans,” Current Topics in Phytochemistry, vol. 4, pp. 121–134, 2000. View at Google Scholar
  49. M. Witvrouw, J. A. Este, M. Q. Mateu et al., “Activity of a sulfated polysaccharide extracted from the red seaweed Aghardhiella tenera against human immunodeficiency virus and other enveloped viruses,” Antiviral Chemistry and Chemotherapy, vol. 5, no. 5, pp. 297–303, 1994. View at Publisher · View at Google Scholar · View at Scopus
  50. M. J. Carlucci, M. Ciancia, M. C. Matulewicz, A. S. Cerezo, and E. B. Damonte, “Antiherpetic activity and mode of action of natural carrageenans of diverse structural types,” Antiviral Research, vol. 43, no. 2, pp. 93–102, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. M. C. Rodríguez, E. R. Merino, C. A. Pujol, E. B. Damonte, A. S. Cerezo, and M. C. Matulewicz, “Galactans from cystocarpic plants of the red seaweed Callophyllis variegata (Kallymeniaceae, Gigartinales),” Carbohydrate Research, vol. 340, no. 18, pp. 2742–2751, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Matsuhiro, A. F. Conte, E. B. Damonte et al., “Structural analysis and antiviral activity of a sulfated galactan from the red seaweed Schizymenia binderi (Gigartinales, Rhodophyta),” Carbohydrate Research, vol. 340, no. 15, pp. 2392–2402, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. L. B. Talarico, M. E. R. Duarte, R. G. M. Zibetti, M. D. Noseda, and E. B. Damonte, “An algal-derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection,” Planta Medica, vol. 73, no. 14, pp. 1464–1468, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Mabeau and B. Kloareg, “Isolation and analysis of the cell walls of brown algae: Fucus spiralis, F. ceranoides, F. vesiculosus, F. serratus, Bifurcaria bifurcata and Laminaria digitata,” Journal of Experimental Botany, vol. 38, no. 9, pp. 1573–1580, 1987. View at Publisher · View at Google Scholar · View at Scopus
  55. W. Wang, S.-X. Wang, and H.-S. Guan, “The antiviral activities and mechanisms of marine polysaccharides: an overview,” Marine Drugs, vol. 10, no. 12, pp. 2795–2816, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. X. Xin, M. Geng, H. Guan, and Z. Li, “Study on the mechanism of inhibitory action of 911 on replication of HIV-1 in vitro,” Chinese Journal of Marine Drugs, vol. 19, no. 4, pp. 15–18, 1999. View at Google Scholar
  57. X. Xianliang, G. Meiyu, G. Huashi, and L. Zelin, “Study on the mechanism of inhibitory action of 911 on replication of HIV-1 in vitro,” Chinese Journal of Marine Drugs, vol. 19, no. 4, pp. 15–22, 2000. View at Google Scholar
  58. B. Jiang, X. Xu, L. Li, and W. Yuan, “Study on ‘911’ anti-HBV effect in HepG2 2115 cells culture,” Modern Preventive Medicine, vol. 30, pp. 517–518, 2003. View at Google Scholar
  59. G. Meiyu, L. Fuchuan, X. Xianliang, L. Jing, Y. Zuowei, and G. Huashi, “The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry: interaction between SPMG and HIV-1 rgp120 and CD4 molecule,” Antiviral Research, vol. 59, no. 2, pp. 127–135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Liu, M. Geng, X. Xin et al., “Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities,” Glycobiology, vol. 15, no. 5, pp. 501–510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. T.-S. Vo and S.-K. Kim, “Potential anti-HIV agents from marine resources: an overview,” Marine Drugs, vol. 8, no. 12, pp. 2871–2892, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. M. S. Patankar, S. Oehninger, T. Barnett, R. L. Williams, and G. F. Clark, “A revised structure for fucoidan may explain some of its biological activities,” The Journal of Biological Chemistry, vol. 268, no. 29, pp. 21770–21776, 1993. View at Google Scholar · View at Scopus
  63. C. P. Dietrich, G. G. M. Farias, L. R. D. de Abreu, E. L. Leite, L. F. da Silva, and H. B. Nader, “A new approach for the characterization of polysaccharides from algae: presence of four main acidic polysaccharides in three species of the class Phaeophycea,” Plant Science, vol. 108, no. 2, pp. 143–153, 1995. View at Publisher · View at Google Scholar · View at Scopus
  64. H. A. de Oliveira Rocha, L. C. Lins de Medeiros Bezerra, I. R. Lopes de Albuquerque et al., “A xylogalactofucan from the brown seaweed Spatoglossum schröederi stimulates the synthesis of an antithrombotic heparan sulfate from endothelial cells,” Planta Medica, vol. 71, no. 4, pp. 379–381, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. C. Boisson-Vidal, F. Haroun, M. Ellouali et al., “Biological activities of polysaccharides from marine algae,” Drugs of the Future, vol. 20, no. 12, pp. 1237–1250, 1995. View at Google Scholar
  66. K. C. S. Queiroz, V. P. Medeiros, L. S. Queiroz et al., “Inhibition of reverse transcriptase activity of HIV by polysaccharides of brown algae,” Biomedicine & Pharmacotherapy, vol. 62, no. 5, pp. 303–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. K. I. P. J. Hidari, N. Takahashi, M. Arihara, M. Nagaoka, K. Morita, and T. Suzuki, “Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga,” Biochemical and Biophysical Research Communications, vol. 376, no. 1, pp. 91–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Akamatsu, M. Shimanaga, and Y. Kamei, “Isolation of an anti-influenza virus substance, MC26 from a marine brown alga, Sargassum piluliferum and its antiviral activity against influenza virus,” Coastal Bioenvironment-Saga University, vol. 1, pp. 29–34, 2003. View at Google Scholar
  69. P. Mandal, C. G. Mateu, K. Chattopadhyay, C. A. Pujol, E. B. Damonte, and B. Ray, “Structural features and antiviral activity of sulphated fucans from the brown seaweed Cystoseira indica,” Antiviral Chemistry and Chemotherapy, vol. 18, no. 3, pp. 153–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. V. H. Pomin and P. A. S. Mourão, “Structure, biology, evolution, and medical importance of sulfated fucans and galactans,” Glycobiology, vol. 18, no. 12, pp. 1016–1027, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. O. Berteau and B. Mulloy, “Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide,” Glycobiology, vol. 13, no. 6, pp. 29R–40R, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Cumashi, N. A. Ushakova, M. E. Preobrazhenskaya et al., “A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds,” Glycobiology, vol. 17, no. 5, pp. 541–552, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Witvrouw and E. De Clercq, “Sulfated polysaccharides extracted from sea algae as potential antiviral drugs,” General Pharmacology: The Vascular System, vol. 29, no. 4, pp. 497–511, 1997. View at Publisher · View at Google Scholar · View at Scopus
  74. E. B. Damonte, M. C. Matulewicz, and A. S. Cerezo, “Sulfated seaweed polysaccharides as antiviral agents,” Current Medicinal Chemistry, vol. 11, no. 18, pp. 2399–2419, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. N. M. A. Ponce, C. A. Pujol, E. B. Damonte, M. L. Flores, and C. A. Stortz, “Fucoidans from the brown seaweed Adenocystis utricularis: extraction methods, antiviral activity and structural studies,” Carbohydrate Research, vol. 338, no. 2, pp. 153–165, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. J.-B. Lee, K. Hayashi, M. Hashimoto, T. Nakano, and T. Hayashi, “Novel antiviral fucoidan from sporophyll of Undaria pinnatifida (Mekabu),” Chemical and Pharmaceutical Bulletin, vol. 52, no. 9, pp. 1091–1094, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. U. Adhikari, C. G. Mateu, K. Chattopadhyay, C. A. Pujol, E. B. Damonte, and B. Ray, “Structure and antiviral activity of sulfated fucans from Stoechospermum marginatum,” Phytochemistry, vol. 67, no. 22, pp. 2474–2482, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. J. A. Hemmingson, R. Falshaw, R. H. Furneaux, and K. Thompson, “Structure and antiviral activity of the galactofucan sulfates extracted from Undaria pinnatifida (Phaeophyta),” Journal of Applied Phycology, vol. 18, no. 2, pp. 185–193, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. K. Hayashi, T. Nakano, M. Hashimoto, K. Kanekiyo, and T. Hayashi, “Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection,” International Immunopharmacology, vol. 8, no. 1, pp. 109–116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Elizondo-Gonzalez, L. E. Cruz-Suarez, D. Ricque-Marie, E. Mendoza-Gamboa, C. Rodriguez-Padilla, and L. M. Trejo-Avila, “In vitro characterization of the antiviral activity of fucoidan from Cladosiphon okamuranus against Newcastle disease virus,” Virology Journal, vol. 9, article 307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. E. L. Leite, M. G. L. Medeiros, H. A. O. Rocha et al., “Structure and pharmacological activities of a sulfated xylofucoglucuronan from the alga Spatoglossum schröederi,” Plant Science, vol. 132, no. 2, pp. 215–228, 1998. View at Publisher · View at Google Scholar · View at Scopus
  82. H. J. Moon, S. R. Lee, S. N. Shim et al., “Fucoidan inhibits UVB-induced MMP-1 expression in human skin fibroblasts,” Biological and Pharmaceutical Bulletin, vol. 31, no. 2, pp. 284–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. F. Haroun-Bouhedja, M. Ellouali, C. Sinquin, and C. Boisson-Vidal, “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Research, vol. 100, no. 5, pp. 453–459, 2000. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Koyanagi, N. Tanigawa, H. Nakagawa, S. Soeda, and H. Shimeno, “Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities,” Biochemical Pharmacology, vol. 65, no. 2, pp. 173–179, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Aisa, Y. Miyakawa, T. Nakazato et al., “Fucoidan induces apoptosis of human HS-Sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways,” American Journal of Hematology, vol. 78, no. 1, pp. 7–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Peat, W. J. Whelan, and H. G. Lawley, “141. The structure of laminarin. Part I. The main polymeric linkage,” Journal of the Chemical Society, pp. 724–728, 1958. View at Publisher · View at Google Scholar · View at Scopus
  87. T. E. Nelson and B. A. Lewis, “Separation and characterization of the soluble and insoluble components of insoluble laminaran,” Carbohydrate Research, vol. 33, no. 1, pp. 63–74, 1974. View at Publisher · View at Google Scholar · View at Scopus
  88. A. O. Chizhov, A. Dell, H. R. Morris et al., “Structural analysis of laminarans by MALDI and FAB mass spectrometry,” Carbohydrate Research, vol. 310, no. 3, pp. 203–210, 1998. View at Publisher · View at Google Scholar · View at Scopus
  89. L.-E. Rioux, S. L. Turgeon, and M. Beaulieu, “Effect of season on the composition of bioactive polysaccharides from the brown seaweed Saccharina longicruris,” Phytochemistry, vol. 70, no. 8, pp. 1069–1075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. J. V. O'Doherty, S. Dillon, S. Figat, J. J. Callan, and T. Sweeney, “The effects of lactose inclusion and seaweed extract derived from Laminaria spp. on performance, digestibility of diet components and microbial populations in newly weaned pigs,” Animal Feed Science and Technology, vol. 157, no. 3-4, pp. 173–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Muto, K. Niimura, M. Oohara et al., “Polysaccharides from marine algae and antiviral drugs containing the same as active ingredients,” European Patent EP295956, vol. 21, 1988.
  92. J.-B. Lee, K. Hayashi, M. Hirata et al., “Antiviral sulfated polysaccharide from Navicula directa, a diatom collected from deep-sea water in Toyama Bay,” Biological and Pharmaceutical Bulletin, vol. 29, no. 10, pp. 2135–2139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. J. H. Yim, S. J. Kim, S. H. Ahn, C. K. Lee, K. T. Rhie, and H. K. Lee, “Antiviral effects of sulfated exopolysaccharide from the marine microalga Gyrodinium impudicum strain KG03,” Marine Biotechnology, vol. 6, no. 1, pp. 17–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Kim, J. H. Yim, S.-Y. Kim et al., “In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03,” Antiviral Research, vol. 93, no. 2, pp. 253–259, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Hasui, M. Matsuda, K. Okutani, and S. Shigeta, “In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses,” International Journal of Biological Macromolecules, vol. 17, no. 5, pp. 293–297, 1995. View at Publisher · View at Google Scholar · View at Scopus
  96. T. Hayashi, K. Hayashi, M. Maeda, and I. Kojima, “Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis,” Journal of Natural Products, vol. 59, no. 1, pp. 83–87, 1996. View at Publisher · View at Google Scholar · View at Scopus
  97. K. Kanekiyo, K. Hayashi, H. Takenaka, J.-B. Lee, and T. Hayashi, “Anti-herpes simplex virus target of an acidic polysaccharide, nostoflan, from the edible blue-green alga Nostoc flagelliforme,” Biological and Pharmaceutical Bulletin, vol. 30, no. 8, pp. 1573–1575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. H. Nakashima, Y. Kido, N. Kobayashi, Y. Motoki, M. Neushul, and N. Yamamoto, “Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from sea algae,” Antimicrobial Agents and Chemotherapy, vol. 31, no. 10, pp. 1524–1528, 1987. View at Publisher · View at Google Scholar · View at Scopus
  99. H. Nakashima, Y. Kido, N. Kobayashi, Y. Motoki, M. Neushul, and N. Yamamoto, “Antiretroviral activity in a marine red alga: reverse transcriptase inhibition by an aqueous extract of Schizymenia pacifica,” Journal of Cancer Research and Clinical Oncology, vol. 113, no. 5, pp. 413–416, 1987. View at Publisher · View at Google Scholar · View at Scopus